Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 50-Week Open-Label, Flexible-Dose Trial of Asenapine Extension Treatment to P06107 in Pediatric Subjects With Acute Manic or Mixed Episodes Associated With Bipolar I Disorder

NCT01349907 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT01349907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01349907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 50-Week Open-Label, Flexible-Dose Trial of Asenapine Extension Treatment to P06107 in Pediatric Subjects With Acute Manic or Mixed Episodes Associated With Bipolar I Disorder
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Completed
Start date
June 16, 2011
Completion date
September 5, 2014
Enrollment
322 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder